2Park DM,Rich JN. Biology of glioma cancer stem cells [J]. Mol Cells,2009,28( 1 ) :7.990.
3Van den Bent MJ,Afra D, De Witte O. Long-term efficacy of early versus delayde radiotherapy for low-grade astrocytoma and oligoden droglima in adults : the EORTC 22845 random- ised trial [J] Lancet,2005,366 (9490) :985-.
4Middleton MR,Grob J J, Aaronson N, et al. Randomized Phase IU study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma[J]. J Clin Oncol,2000,18( 1 ) :158-166.
5Szczepanek D, Marche A. Efficacy of concomitant and adju- vant temozolomide in glioblastoma treatment. A multicentre randomized study [J]Neurol Neurochir Pol, 2013,47 ( 2 ) : 101-108.
6Asthagiri AR,Pouratian N, Sherman J, et al. Advances in brain tumor surgery [J] Neurol Clin, 2007,25 ( 4 ) : 975 -1003.
7He C, Bartholomew CR, Zhou W, et al. Assaying autophagic activity in transgenic GFP-Lc3 and GPF-Gabarap zebrafish em- bryos [ J ]. Autophagy ,2009,5 (4) :520-526.
8Stupp R, Hegi ME. Recent developments in the management of malignant glioma. In ; Perry MC, ed. ASCO 2003 educational book. Alexandria, Va. American Society of Clinical Oncology, 2003:779-88.
9Shapiro WR. Chemotherapy of malignant gliomas, studies of the BTCG[J]. Rev Neurol, 1992,148:428-34.
10Grossman SA, O' Neill A, Grunnet M, et al. Phase 11 study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and con- current carmustine in patients with newly diagnosed supratento- rial glioblastoma multiforme; Eastern Cooperative Oncology Group Trial 2394 [J]. J Clin Onco1,2003,21 : 1485-1491.
